市传电竞公司VSPN考虑最快今年在美上市
《彭博通讯社》引述消息人士报道,中国电竞公司英雄体育VSPN正考虑最快今年在美国上市,以扩大其在充满竞争的中国游戏领域中的实力。据了解,公司计划上市集资数亿美元。而有关商讨只是在初期阶段,规模及时间表等细节可能有变。
据官网介绍,公司成立於2016年,以电竞赛事及内容制作为核心,提供电竞商业化、电竞综合体运营、电竞潮流文化IP运营等综合服务。业务覆盖亚洲、欧洲、美洲,制作播出共计13,000场顶级赛事。
根据1月份的公布,公司在B+轮融资集资6,000万美元,投资者包括国泰君安及Prospect Avenue Capital,还有快手(01024.HK)、红杉资本及腾讯(00700.HK)等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.